H
Harlan M. Krumholz
Researcher at Yale University
Publications - 1966
Citations - 177853
Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.
Papers
More filters
Journal ArticleDOI
Relationship Between Age and Trajectories of Rehospitalization Risk in Older Adults.
TL;DR: The magnitude and duration of risk of rehospitalization according to age after hospitalization for heart failure, acute myocardial infarction, or pneumonia is characterized.
Posted ContentDOI
Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient-and-Summary-Level Meta-Analyses
Joshua D. Wallach,Kun Wang,Audrey D Zhang,Deanna Chang,Holly K. Grossetta Nardini,Haiqun Lin,Michael B. Bracken,Mayur M. Desai,Harlan M. Krumholz,Joseph S. Ross +9 more
TL;DR: It is suggested that rosiglitazone is consistently associated with an increased cardiovascular risk, likely driven by heart failure events, whose interpretation is complicated by varying magnitudes of myocardial infarction risk that were attenuated through aggregation of summary-level data in addition to IPD.
Journal ArticleDOI
Age of Data at the Time of Publication of Contemporary Clinical Trials.
John Welsh,Yuan Lu,Sanket S. Dhruva,Sanket S. Dhruva,Behnood Bikdeli,Behnood Bikdeli,Nihar R. Desai,Liliya Benchetrit,Chloe O. Zimmerman,Lin Mu,Joseph S. Ross,Harlan M. Krumholz +11 more
TL;DR: For a substantial proportion of studies, time for enrollment and time from completion of data collection to publication were quite long, indicating marked opportunities for improvement in clinical trials to reduce data age.
Posted ContentDOI
Change in Symptoms and Immune Response in People with Post-Acute Sequelae of SARS-Cov-2 Infection (PASC) After SARS-Cov-2 Vaccination
Daisy Massey,Diana Berrent,Athena Akrami,Gina S. Assaf,Hannah E. Davis,Karen Harris,Lisa McCorkell,Aaron M. Ring,Wade L. Schulz,Hannah Wei,Harlan M. Krumholz,Akiko Iwasaki,Akiko Iwasaki +12 more
TL;DR: In this article, the authors conducted a study that measured the changes in Post-Acute Sequelae (PASC) symptoms after vaccination, collecting baseline self-report and biospecimens for immune assays and then are following up with participants to collect the same data at 2 weeks, 6 weeks, and 12 weeks post-vaccination.
Journal ArticleDOI
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.
Jacob McPadden,Frederick Warner,H. Patrick Young,Nathan C. Hurley,Rebecca Pulk,Avinainder Singh,Thomas J S Durant,Guannan Gong,Nihar R. Desai,Adrian D. Haimovich,Richard Andrew Taylor,Murat Gunel,Charles S. Dela Cruz,Shelli F. Farhadian,Jonathan M. Siner,Merceditas Villanueva,Keith Churchwell,Allen L. Hsiao,Charles J Torre,Eric J. Velazquez,Roy S. Herbst,Akiko Iwasaki,Akiko Iwasaki,Albert I. Ko,Bobak J. Mortazavi,Harlan M. Krumholz,Wade L. Schulz +26 more
TL;DR: In this article, the authors identified risk factors associated with admission and disease severity in patients with severe acute respiratory syndrome virus (SARS-CoV-2) infection as determined by RT-PCR testing and assessed features associated with the need for respiratory support.